X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9701) 9701
Magazine Article (59) 59
Book Chapter (37) 37
Newsletter (27) 27
Book / eBook (7) 7
Book Review (3) 3
Conference Proceeding (2) 2
Dissertation (2) 2
Newspaper Article (2) 2
Report (2) 2
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8036) 8036
carbamazepine - therapeutic use (5034) 5034
carbamazepine (5030) 5030
male (4556) 4556
female (4319) 4319
anticonvulsants - therapeutic use (3648) 3648
adult (3459) 3459
clinical neurology (2722) 2722
epilepsy - drug therapy (2548) 2548
index medicus (2529) 2529
middle aged (2337) 2337
epilepsy (2240) 2240
pharmacology & pharmacy (1909) 1909
adolescent (1854) 1854
anticonvulsants - adverse effects (1563) 1563
child (1518) 1518
carbamazepine - adverse effects (1517) 1517
psychiatry (1500) 1500
antiepileptic drugs (1389) 1389
aged (1336) 1336
valproic acid - therapeutic use (1181) 1181
anticonvulsants (1135) 1135
drug therapy, combination (1108) 1108
treatment outcome (1056) 1056
neurosciences (1025) 1025
animals (998) 998
phenytoin (949) 949
lamotrigine (929) 929
seizures (928) 928
carbamazepine - analogs & derivatives (846) 846
bipolar disorder - drug therapy (790) 790
phenytoin - therapeutic use (790) 790
double-blind (788) 788
drug interactions (765) 765
child, preschool (751) 751
dose-response relationship, drug (733) 733
carbamazepine - administration & dosage (732) 732
neurology (731) 731
drugs (689) 689
carbamazepine - blood (674) 674
valproic acid (672) 672
oxcarbazepine (657) 657
carbamazepine - pharmacology (656) 656
children (639) 639
valproate (606) 606
anticonvulsants - administration & dosage (605) 605
anticonvulsants - pharmacology (602) 602
drug therapy (595) 595
pharmacokinetics (577) 577
analysis (565) 565
anticonvulsants - pharmacokinetics (553) 553
electroencephalography (549) 549
efficacy (496) 496
seizures - drug therapy (493) 493
epilepsies, partial - drug therapy (488) 488
bipolar disorder (487) 487
carbamazepine - pharmacokinetics (465) 465
retrospective studies (458) 458
phenobarbital - therapeutic use (446) 446
time factors (438) 438
double-blind method (435) 435
triazines - therapeutic use (427) 427
rats (426) 426
epilepsy - blood (425) 425
young adult (422) 422
antipsychotic agents - therapeutic use (421) 421
therapy (417) 417
anticonvulsants - blood (416) 416
lithium (411) 411
medicine, general & internal (406) 406
infant (399) 399
pediatrics (397) 397
follow-up studies (394) 394
pregnancy (393) 393
valproic acid - adverse effects (388) 388
sodium valproate (386) 386
risk factors (384) 384
monotherapy (378) 378
antimanic agents - therapeutic use (372) 372
lithium - therapeutic use (372) 372
gabapentin (364) 364
topiramate (358) 358
care and treatment (355) 355
medicine & public health (347) 347
clinical trials as topic (344) 344
drug administration schedule (332) 332
prospective studies (329) 329
toxicology (323) 323
mice (320) 320
trigeminal neuralgia - drug therapy (313) 313
aged, 80 and over (303) 303
research (302) 302
bipolar disorder - psychology (299) 299
health aspects (289) 289
magnetic resonance imaging (272) 272
diagnosis, differential (270) 270
metabolism (265) 265
epilepsy - physiopathology (258) 258
randomized controlled trials as topic (254) 254
pharmacology/toxicology (252) 252
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8776) 8776
German (261) 261
Spanish (187) 187
French (184) 184
Russian (102) 102
Japanese (91) 91
Polish (68) 68
Italian (60) 60
Chinese (28) 28
Portuguese (27) 27
Dutch (22) 22
Hungarian (16) 16
Norwegian (14) 14
Danish (12) 12
Finnish (10) 10
Hebrew (9) 9
Croatian (7) 7
Swedish (7) 7
Czech (5) 5
Serbian (5) 5
Lithuanian (3) 3
Romanian (3) 3
Slovak (3) 3
Turkish (3) 3
Ukrainian (3) 3
Korean (2) 2
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 03/2018, Volume 2018, Issue 3, p. CD011481
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2011, Volume 10, Issue 7, pp. 609 - 617
Journal Article
Journal Article
Book Review
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2015, Volume 2017, Issue 6, p. CD011091
Background Neuropathic pain, which is caused by nerve damage, is increasing in prevalence worldwide. This may reflect improved diagnosis, or it may be due to... 
Analgesics, Non‐Narcotic | Painful neuropathy | Off‐Label Use | Patient Dropouts | Pain & anaesthesia | Management | Peripheral neuropathy | 2019 3. Chronic pain | Carbamazepine | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride | Imipramine | Neurology | Chronic non‐cancer pain | 2019 3.1 Neuropathic pain | Antidepressive Agents, Second‐Generation | Neuralgia | Pharmacological therapies | Medicine General & Introductory Medical Sciences | Off-Label Use | PERIPHERAL DIABETIC-NEUROPATHY | ANTIDEPRESSANT | Carbamazepine [therapeutic use] | EFFICACY | Humans | Middle Aged | TREATMENT OUTCOMES | Analgesics, Non-Narcotic [adverse effects; therapeutic use] | Neuralgia [drug therapy] | MEDICINE, GENERAL & INTERNAL | Imipramine [therapeutic use] | Venlafaxine Hydrochloride [adverse effects; therapeutic use] | Antidepressive Agents, Second-Generation [adverse effects;therapeutic use] | FIBROMYALGIA | CLINICAL-TRIALS | DOUBLE-BLIND | Adult | TRIGEMINAL NEURALGIA | QUALITY-OF-LIFE | EXTENDED-RELEASE | Antidepressive Agents, Second-Generation - adverse effects | Imipramine - therapeutic use | Carbamazepine - therapeutic use | Analgesics, Non-Narcotic - therapeutic use | Venlafaxine Hydrochloride - therapeutic use | Antidepressive Agents, Second-Generation - therapeutic use | Neuralgia - drug therapy | Venlafaxine Hydrochloride - adverse effects | Analgesics, Non-Narcotic - adverse effects
Journal Article
Epilepsia, ISSN 0013-9580, 10/2017, Volume 58, Issue 10, pp. 1734 - 1741
Summary Objective Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is a common epilepsy syndrome that is often poorly controlled by... 
Drug response | Efficacy | Adverse drug reactions | Retention | Seizure freedom | CONTROLLED-TRIAL | REFRACTORY EPILEPSY | PROGNOSIS | LOCALIZATION-RELATED EPILEPSY | TOPIRAMATE | RETENTION RATES | NATURAL-HISTORY | CLINICAL NEUROLOGY | THERAPY | LAMOTRIGINE | RESISTANT EPILEPSY | Pregabalin - therapeutic use | Triazines - therapeutic use | Humans | Middle Aged | Epilepsy, Temporal Lobe - drug therapy | Epilepsy, Temporal Lobe - physiopathology | Male | Sclerosis | Young Adult | Amines - therapeutic use | Vision Disorders - chemically induced | Adult | Female | Valproic Acid - therapeutic use | Retrospective Studies | gamma-Aminobutyric Acid - therapeutic use | Epilepsy, Temporal Lobe - pathology | Databases, Factual | Diplopia - chemically induced | Cyclohexanecarboxylic Acids - therapeutic use | Carbamazepine - analogs & derivatives | Vertigo - chemically induced | Dizziness - chemically induced | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Treatment Outcome | Hippocampus - pathology | Lethargy - chemically induced | Fructose - therapeutic use | Fructose - analogs & derivatives | Vigabatrin - therapeutic use | Adolescent | Aged | Ataxia - chemically induced | Benzodiazepines - therapeutic use | Medical research | Care and treatment | Anticonvulsants | Medicine, Experimental | Temporal lobe epilepsy | Seizures (Medicine) | Comparative analysis | Topiramate | Temporal lobe | Gabapentin | Epilepsy | Clinical trials | Valproic acid | Antiepileptic agents | Carbamazepine | Vertigo | Oxcarbazepine | Convulsions & seizures | Drowsiness | Ataxia | Hippocampus | Lamotrigine
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 2/2015, Volume 23, Issue 2, pp. 513 - 524
...Support Care Cancer (2015) 23:513 – 524 DOI 10.1007/s00520-014-2408-8 REVIEW ARTICLE Current use of drugs affecting the central nervous system for chemotherapy... 
Pain Medicine | Anticonvulsants | Chemotherapy | Nursing | Rehabilitation Medicine | Medicine & Public Health | Antidepressants | Oncology | Peripheral neuropathy | Nursing Management/Nursing Research | Cancer | CONTROLLED-TRIAL | MANAGEMENT | EFFICACY | PREVENTION | GABAPENTIN | OXALIPLATIN-RELATED NEUROTOXICITY | PAIN | ONCOLOGY | COLORECTAL-CANCER | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | REHABILITATION | QUALITY-OF-LIFE | Thiophenes - therapeutic use | Peripheral Nervous System Diseases - chemically induced | Humans | Boronic Acids - adverse effects | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Epothilones - therapeutic use | Boronic Acids - therapeutic use | Epothilones - adverse effects | Taxoids - therapeutic use | Antineoplastic Agents - adverse effects | Taxoids - adverse effects | Thalidomide - adverse effects | Bortezomib | Carbamazepine - analogs & derivatives | Vinca Alkaloids - adverse effects | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Vinca Alkaloids - therapeutic use | Neuralgia - drug therapy | Neoplasms - drug therapy | Antidepressive Agents - therapeutic use | Venlafaxine Hydrochloride | Pyrazines - adverse effects | Central Nervous System - drug effects | Cyclohexanols - therapeutic use | Duloxetine Hydrochloride | Amitriptyline - therapeutic use | Thalidomide - therapeutic use | Peripheral Nervous System Diseases - drug therapy | Drugs | Cancer patients | Care and treatment | Central nervous system | Nervous system | Drug therapy | Neuropathology
Journal Article
Journal Article